Waksal Harlan 4
4 · Lyra Therapeutics, Inc. · Filed Apr 13, 2022
Insider Transaction Report
Form 4
Waksal Harlan
DirectorExecutive Chair
Transactions
- Purchase
Common Stock
2022-04-12$4.22/sh+236,966$999,997→ 236,966 total
4 · Lyra Therapeutics, Inc. · Filed Apr 13, 2022
Common Stock